What is CTSO's gross margin?

Cytosorbents (CTSO) has a gross margin of 73% and a net margin of -46%.

What is CTSO's P/E ratio?

Track Cytosorbents (CTSO) P/E ratio, ROE, and valuation metrics over time.

Where can I see CTSO's full financials?

See Cytosorbents (CTSO) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Cytosorbents (CTSO) Financials — Revenue, Earnings, Cash Flow

$4.05

-0.14 (-3.23%)

Weekly Expected Move ±10.2%

$3 $3 $4 $4 $5

NASDAQ · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 32 · $12.7M mcap · 3M float · 0.453% daily turnover · Short 47% of daily vol

📊 Key Metrics

TTM

$37M

Revenue

+3.1% YoY

$-18M

Net Income

-86.8% YoY

$-10M

Free Cash Flow

-1.4% YoY

73.2%

Gross Margin

-27.4%

Op. Margin

-45.9%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-336.2%

ROA-42.4%

ROIC-46.3%

Valuation

P/E-0.7

P/B-16.9

EV/EBITDA-3.1

Leverage

Debt/Equity-35.07

Current Ratio0.66

Interest Cov.-11.1x

Quality Scores

Piotroski F4/9

Altman Z-12.13

Beneish M-3.65